Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,21172,859,1.36 [1.07-1.72],0.0117571911362754
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21120,165,1.71 [1.02-2.89],0.0429889169458419
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16114,647,1.67 [1.26-2.21],0.000307663354782
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Mycoses,23761,58,2.30 [1.02-5.18],0.0437512424272824
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",20221,585,1.52 [1.15-2.02],0.0035875083831445
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,21628,893,1.30 [1.03-1.65],0.0304868946173969
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,24167,61,2.38 [1.14-4.96],0.0202573916792821
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),21440,346,2.33 [1.64-3.31],2.0179585895987337e-06
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,20106,776,1.46 [1.13-1.87],0.0032215651181031
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,22593,97,3.35 [1.87-5.99],4.5421436471085793e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23319,49,2.49 [1.03-6.01],0.0427918311413933
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22584,88,3.60 [2.00-6.49],2.0292834331756245e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,22853,357,1.45 [1.01-2.09],0.0416506569192231
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19936,606,1.37 [1.03-1.82],0.0316179919092515
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,19894,564,1.40 [1.05-1.88],0.0237036891241341
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",24030,38,2.95 [1.06-8.24],0.0383902103742041
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,Alcohol dependence,22932,23,3.75 [1.18-11.90],0.025073730819146
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20227,321,1.63 [1.11-2.39],0.0125444857692821
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,Depression,22448,286,1.65 [1.10-2.46],0.014778481183861
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,Depression or dysthymia,20045,248,1.77 [1.15-2.72],0.009738343589794
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Neurological diseases,20968,1420,1.30 [1.08-1.58],0.006146370404094
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23063,372,1.74 [1.22-2.47],0.0020299701808549
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Epilepsy,22808,117,3.85 [2.26-6.56],6.943138104286792e-07
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20752,365,1.48 [1.05-2.09],0.0239240304716094
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23983,29,4.09 [1.81-9.24],0.000728979756918
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1555,29,3.66 [1.46-9.20],0.0057314648826323
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",22457,29,4.44 [1.89-10.41],0.0006177813030766
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,17799,2425,1.22 [1.03-1.43],0.0186173785984244
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23713,68,3.18 [1.66-6.10],0.0005087683850411
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,14699,242,2.59 [1.68-3.99],1.794824797772157e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21076,50,2.49 [1.05-5.88],0.0379985854999211
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23341,59,2.75 [1.23-6.17],0.0139764990795498
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,24014,113,1.88 [1.02-3.48],0.0446539005242822
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23923,78,3.10 [1.72-5.59],0.000175919404299
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Interstitial lung disease,22591,60,4.07 [2.27-7.30],2.4677854799077625e-06
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",23987,60,4.08 [2.26-7.35],2.868096555589572e-06
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22584,53,3.53 [1.84-6.75],0.0001382755493052
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pleural effusion,22597,76,2.48 [1.19-5.16],0.0152264793222814
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23179,81,0.39 [0.18-0.86],0.0200827131728189
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18312,190,1.72 [1.07-2.76],0.02459085968474
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Oesophagitis,18378,256,1.78 [1.19-2.66],0.0050155712583868
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23261,808,1.39 [1.09-1.78],0.0090026027129443
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22514,61,2.65 [1.19-5.92],0.0172775901961413
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",24075,116,2.05 [1.12-3.75],0.0192834138657424
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Ulcerative colitis,22569,116,2.08 [1.14-3.79],0.0165598411284991
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22555,102,2.14 [1.13-4.03],0.0189258780642053
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23129,676,1.32 [1.01-1.73],0.0409593468298929
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,17630,339,1.67 [1.15-2.43],0.0073264778321005
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Constipation,22735,304,1.70 [1.17-2.49],0.005975645350484
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of liver,23521,90,2.98 [1.66-5.36],0.0002539489355864
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of liver,23479,48,2.73 [1.20-6.20],0.0165327501081432
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22119,58,2.46 [1.08-5.60],0.0312898332955709
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23482,292,1.62 [1.09-2.41],0.0162180309062545
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23923,57,2.51 [1.11-5.70],0.0279015917153315
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23910,44,2.75 [1.10-6.86],0.030484793148768
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,17032,3873,1.38 [1.21-1.57],2.0730861474503466e-06
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,18581,2222,1.51 [1.29-1.77],3.1115599903004376e-07
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16552,193,2.88 [1.86-4.44],1.929795420115047e-06
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16815,456,1.83 [1.33-2.50],0.0001694713403294
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23703,185,2.68 [1.74-4.15],8.56518114254968e-06
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23718,170,2.80 [1.79-4.37],5.843645342226119e-06
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,17429,1070,1.79 [1.44-2.23],1.470143070464599e-07
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",19815,1070,1.74 [1.41-2.15],3.348221186241626e-07
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16435,76,2.93 [1.66-5.19],0.0002257194201041
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,16635,276,2.02 [1.36-2.98],0.0004291692203952
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,16773,414,1.67 [1.21-2.31],0.0018978873158017
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,16772,413,1.78 [1.28-2.49],0.0006366971898398
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,17602,1243,1.40 [1.14-1.71],0.0011663360971847
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16459,100,2.30 [1.24-4.25],0.008165953170182
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18023,262,2.15 [1.47-3.15],9.022025179557345e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,20916,277,1.53 [1.02-2.29],0.0406366796095287
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,21553,914,1.44 [1.14-1.82],0.0019417254260916
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21368,729,1.54 [1.19-2.00],0.000927238309057
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20715,76,2.73 [1.43-5.22],0.0023152000504572
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20708,69,2.57 [1.23-5.37],0.0119299398812365
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20958,319,1.53 [1.04-2.24],0.0299122241994153
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21029,481,1.37 [1.01-1.88],0.04639900257064
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20811,263,1.67 [1.12-2.51],0.0127451076762963
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22000,420,1.68 [1.21-2.32],0.001847264560372
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21614,34,4.23 [1.94-9.22],0.0002837101585264
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,19857,5411,1.16 [1.04-1.30],0.00946488123917
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,18125,104,2.17 [1.13-4.14],0.0191987700791537
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Irregular menses,24111,410,1.50 [1.06-2.12],0.0206093813728259
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",19202,1181,1.43 [1.15-1.77],0.0010603865067713
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Menorrhagia,18789,768,1.44 [1.11-1.87],0.0062591635153689
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,18296,275,1.70 [1.11-2.62],0.0150888086486208
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,24203,1014,0.73 [0.56-0.95],0.0172914582898354
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,24050,206,0.61 [0.37-1.00],0.0484342965010113
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,23585,124,0.42 [0.22-0.81],0.0090169536258614
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",24218,148,0.50 [0.28-0.90],0.0213531601119568
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,22985,113,0.50 [0.25-0.98],0.0443278296423209
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23958,42,2.58 [1.07-6.21],0.0345216182202107
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Falls/tendency to fall,21685,545,2.04 [1.54-2.70],6.103218219947843e-07
